A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

NCT05079698 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 177Lu-PSMA-617
PROCEDURE: Stereotactic Body Radiotherapy (SBRT)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]